Author

C. Blish

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1

Frequent Co-Authors

A. Beck· 1 shared A. Drelich· 1 shared A. Kay· 1 shared A. Leibar· 1 shared A. Linares· 1 shared A. Rustagi· 1 shared B.-H. Peng· 1 shared C. Dekker· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Beck

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Design of SARS-CoV-2 protease inhibitors with improved affinity and reduced sensitivity to mutations

M. Westberg, Y. Su, X. Zou, P. Huang, A. Rustagi, J. Garhyan, P. B. Patel, D. Fernandez, Y. Wu, L. Ning, A. Beck, M. Karim, C. Hao, P. Saenkham-Huntsinger, V. Tat, , M. Z. Lin

This study designs a SARS-CoV-2 protease inhibitor with improved affinity and reduced mutation sensitivity compared to existing drugs.

bioRxiv · Jul 19, 2023 · PreprintMicrobiology

CyTOF analysis identifies unusual immune cells in urine of BCG-treated bladder cancer patients

E. Castellano, C. Samba, G. Esteso, L. J. Simpson, E. Vendrame, E. M. Garcia-Cuesta, S. Lopez-Cobo, M. Alvarez-Maestro, A. Linares, A. Leibar, T. Ranganath, H. T. Reyburn, L. Martinez-Pineiro, C. Blish, M. Vales-Gomez

The paper uses CyTOF to identify a novel immune cell population in urine of BCG-treated bladder cancer patients, linking it to inflammatory response and potential treatment risk.

bioRxiv · Jun 12, 2020Immunology

CD38 contributes to human natural killer cell responses through a role in immune synapse formation

M. Le Gars, C. Seiler, A. Kay, N. Bayless, E. Sola, E. Starosvetsky, L. Moore, S. Shen-Orr, N. Aziz, C. Dekker, P. Khatri, G. Swan, M. Davis, S. Holmes, C. Blish

This study identifies CD38 as a key receptor in human NK cells that facilitates immune synapse formation, enhancing antiviral and antitumor responses.

bioRxiv · May 24, 2019 · PreprintImmunology